Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients.
about
How Neutrophils Shape Adaptive Immune ResponsesRegulation of tumor metastasis by myeloid-derived suppressor cellsNeutrophils and Granulocytic MDSC: The Janus God of Cancer ImmunotherapyTumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophagesTumor-induced myeloid dysfunction and its implications for cancer immunotherapyComplexity and challenges in defining myeloid-derived suppressor cellsImpact of the Sensory Neurons on Melanoma Growth In VivoAtorvastatin (Lipitor) attenuates the effects of aspirin on pancreatic cancerogenesis and the chemotherapeutic efficacy of gemcitabine on pancreatic cancer by promoting M2 polarized tumor associated macrophages.Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and ExtentContributions of neutrophils to the adaptive immune response in autoimmune disease.Priming of neutrophils toward NETosis promotes tumor growth.Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancerThe diverse roles of the TNF axis in cancer progression and metastasis.Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer PatientsPancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer.Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer.Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.A clinical and biological perspective of human myeloid-derived suppressor cells in cancer.On the origin of myeloid-derived suppressor cells.Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade.Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity.GM-CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid-derived suppressor cells in vitro.A subpopulation that may correspond to granulocytic myeloid-derived suppressor cells reflects the clinical stage and progression of cutaneous melanoma.Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma.Increased circulating myeloid-derived suppressor cells correlate with cancer stages, interleukin-8 and -6 in prostate cancer.CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis.Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells.Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.Myeloid-derived suppressor cells in ovarian cancer: friend or foe?CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma.The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma.Association of Chemokines and Chemokine Receptor Expression with Monocytic-Myeloid-Derived Suppressor Cells during Tumor Progression.p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation
P2860
Q26781286-0772C8DE-EEBF-423E-8173-A5E97F6B8E3CQ27022125-CF4BE9EC-36AB-4ACD-8182-578041DD28E6Q28069360-18C82515-CDAD-49D0-BF18-30D63B03386EQ34044797-61AD124D-437A-4532-B088-5E5C96AF5BCDQ34810257-FF47D333-75BD-42DA-8FDA-32E88B4A2C20Q35509317-41CEDA04-161A-47F5-B13C-AFEB32398CDFQ36029972-9D7748DD-4235-4B66-B793-2992E9BD9AC6Q36584020-624AF2CA-7499-465F-A444-D3E243AE3B8FQ36683267-D12499C4-57E8-4FF5-A9AE-57AE6842CBA6Q36751862-5A345A65-73DC-4F9E-94F7-60F3BBAB3E95Q37012590-6B290E8B-F683-4D5E-88EF-05978AB02AFAQ37294755-4FA0BA88-83DF-4E53-9A83-415E405E579FQ37474735-0E9139F7-BB1A-42ED-AEB9-184101683E1FQ37483023-D3606A6A-2A5D-40AD-B7CA-EDDA4D8C4D15Q37588378-CC75750E-4F88-46C1-9CAC-0B075293311DQ38528814-CBF46CF9-21D5-48F9-BF9A-D848FE158D9BQ38666705-E793E128-8FC9-462D-83BA-6A2DBFFFEA6BQ38702891-5556D725-CBA3-4154-80EB-F61EF134DA1FQ38847251-C996F70B-6404-41EE-9C7B-91C5F9300F72Q38968944-54655079-1C05-4B0F-A270-91E7BB3DEA2BQ38998454-E5D7C037-2AD8-4320-A60F-669C5D018396Q39144794-775DF6A6-1F97-465A-B8CA-D6D301F8AD67Q40032613-905BE09E-7F3B-4030-908A-BF7F16EABDAAQ41338809-F5B8A345-536C-45D8-9748-43A5B219E15DQ41858851-86985619-1E58-4A5D-9BC0-F3DEC78C4F2BQ43015717-439572FB-8AAA-4E80-81FE-AE08F1BB6F12Q43055825-92C6EFB2-2B71-49A9-9BD9-A9A1E5B4CB9BQ46045585-B20D8EAE-D5E3-48B8-94D5-F47151A5AA95Q48583884-F7263870-6B5C-43E0-8683-A401C9ACB704Q50097927-D76AAF05-FDF5-4584-A132-5964DC2E2EC1Q52689050-299D3880-5B09-4007-AD24-C6EB2775FE43Q52886494-6FF8F03F-5110-46EA-A5DD-720948C5DA43Q55443866-F13863CF-82AE-4F2E-AA17-C74D48BAEF6DQ55516375-B33FEA6E-3C03-49BE-A5C6-0DEF126096EDQ58760423-437CF9B5-F36C-474B-8C4B-ADB7AF513CCC
P2860
Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased levels of granulocyt ...... of pancreatic cancer patients.
@en
Increased levels of granulocyt ...... of pancreatic cancer patients.
@nl
type
label
Increased levels of granulocyt ...... of pancreatic cancer patients.
@en
Increased levels of granulocyt ...... of pancreatic cancer patients.
@nl
prefLabel
Increased levels of granulocyt ...... of pancreatic cancer patients.
@en
Increased levels of granulocyt ...... of pancreatic cancer patients.
@nl
P2860
P356
P1476
Increased levels of granulocyt ...... of pancreatic cancer patients.
@en
P2093
Basil J Ammori
P2860
P304
P356
10.1155/2014/879897
P577
2014-01-29T00:00:00Z